ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Internal Medicine

Top Internal Medicine Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ITRI EREN MD

Internal Medicine

79,024

$4.84M

1615
1385 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

SABIR QURAISHI M.D.

Internal Medicine

46,821

$2.66M

950
587 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $61

HAITHAM AZEM M.D.

Internal Medicine

41,393

$2.18M

1071
868 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $61

BRIAN MCCLAIN M.D.

Internal Medicine

39,927

$2.62M

1244
1106 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $61

SANTUCCIO RICCIARDI MD

Internal Medicine

39,037

$2.42M

1205
1007 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $61

JYOTI MEHTA MD

Internal Medicine

37,374

$1.98M

790
610 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $61

AJAY CHAWLA MD

Internal Medicine

37,049

$2.15M

1198
1049 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

FREDERICK CARROLL M.D.

Internal Medicine

36,857

$2.09M

988
737 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $61

JILIAN WAITE M.D.

Internal Medicine

36,703

$2.13M

815
609 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

RUFUS REUBEN MD

Internal Medicine

33,285

$2.29M

565
485 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

ANTON VASILIU MD

Internal Medicine

32,929

$1.8M

854
819 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

VIJETH SRINGERI M.D.

Internal Medicine

32,488

$1.77M

954
770 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

THOMAS SARGERO MD

Internal Medicine

31,758

$2.52M

700
449 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $61

DORAI RAJAN M.D.

Internal Medicine

31,509

$2.02M

804
534 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

EMAD ELBADAWY M.D.

Internal Medicine

31,242

$1.8M

848
500 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

WILLIAM SHADE

Internal Medicine

30,752

$1.69M

924
838 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

THOMAS MANDAT MD

Internal Medicine

29,721

$1.75M

787
635 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

CHENGUTTAI MANOHAR MD

Internal Medicine

29,170

$1.64M

664
537 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

AUDRIUS RUKSENAS M.D.

Internal Medicine

28,978

$1.74M

556
502 are 65+

18%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $61

IRINA PAPIROVA MD

Internal Medicine

28,198

$1.89M

606
568 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $61

MEHRDAD TAVALLAEE MD

Internal Medicine

27,958

$1.32M

808
615 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $61

WILLIAM MILLS M.D.

Internal Medicine

27,322

$1.48M

704
683 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

MARK SMITH MD

Internal Medicine

26,649

$1.36M

819
682 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $61

KAMLESH AGGARWAL MD

Internal Medicine

26,487

$1.27M

649
500 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $61

HAZEM NOURALDIN MD

Internal Medicine

26,354

$1.57M

557
348 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank